相关实验视频

Updated: Sep 19, 2025

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

对基于细胞外囊泡的疫苗的免疫反应,表达SARS-CoV-2结构蛋白的完整套件

Tamanna Mustajab¹, Moriasi Sheba Kwamboka², Imran Khan¹

¹Department of Microbiology, Ajou University School of Medicine, Suwon, Gyeonggi-do 16499, South Korea; Department of Biomedical Science, Graduate School of Ajou University, Suwon, Gyeonggi-do 16499, South Korea.

|June 18, 2025

概括

研究人员使用外细胞囊泡 (EV) 开发了一种新型的COVID-19疫苗,该囊泡被设计为显示SARS-CoV-2结构蛋白. 这种通用疫苗候选者在小鼠中表现出强大的抗体和T细胞反应,提供了对变种的潜在保护.

科学领域:

疫苗学疫苗学疫苗学
免疫学免疫学免疫学
生物技术是生物技术.

背景情况:

目前的COVID-19疫苗主要针对尖蛋白.
需要疫苗提供更广泛的保护,防止新出现的SARS-CoV-2变种和未来的流行病威胁.

研究的目的:

开发一种基于细胞外囊泡 (EV) 的新型候选疫苗,用于抗击COVID-19.
为了设计EV来表达SARS-CoV-2结构蛋白的完整组 (Spike, Nucleocapsid, Membrane, Envelope).
评估这些工程电动汽车的免疫性和保护潜力.

主要方法:

在293个T细胞中表达了SARS-CoV-2结构蛋白 (Spike变体,核体,膜,包裹).
收集了与细胞死亡相关的EV,并对蛋白质负载进行了表征.
鼠被用工程EVs免疫,并评估了抗体和T细胞反应.

主要成果:

设计的EV成功地结合了SARS-CoV-2的Spike (S),Nucleocapsid (N),Membrane (M) 和Envelope (E) 蛋白.
在小鼠中,EV免疫诱导了针对S和N蛋白的显著IgG抗体反应.
增强免疫产生了对S和N蛋白的CD4+ T辅助1 (TH1) 和CD8+细胞毒性T (TC) 细胞的记忆.

结论:

表达SARS-CoV-2蛋白质的细胞外囊泡代表了一个可行的通用疫苗候选人.
这种基于EV的疫苗方法显示了对当前和未来的SARS-CoV-2变种的保护潜力.
该研究强调了电动汽车作为开发新兴传染病疫苗的平台的潜力.

关键词:

基于 EV 的疫苗.细胞外囊泡 (EVs) 是一种细胞外囊泡.在SARS-CoV-2的结构蛋白中.尖蛋白质是一种尖蛋白质.

更多相关视频

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

相关概念视频

Vaccinations

Vaccinations

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Conjugated Proteins

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...

Humoral Immune Responses

Humoral Immune Responses

Cross-reactivity

Cross-reactivity

Viral Structure

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.